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A highly efficient lambda phage recombination system previously utilized for studies of bacterial artificial
chromosome (BAC)-maintained mouse chromosomal DNA was adapted for the study of the role of human
cytomegalovirus (HCMV)-encoded pp28 (UL99) in virus replication. Incorporating a two-step mutagenesis
strategy with blue/white selection in Escherichia coli containing a HCMV AD169 BAC, we have shown that we
can rapidly introduce point mutations into the HCMV BAC using linear PCR fragments. All manipulations
were carried out in bacteria, which greatly accelerated the introduction and analysis of mutations in the viral
genome. Our results indicated that HCMV pp28 was essential for the production of infectious virus and that
introduction of a single base change that resulted in loss of the myristylation site on pp28 was also associated
with the lack of production of infectious virus. Although the block in the viral morphogenesis cannot be
determined from these studies, the latter finding suggested that authentic intracellular localization of pp28, not
only the expression of the protein, is required for virus assembly.
The role of individual herpesvirus genes in virus replication
and the pathogenesis of virus-induced disease have been best
understood from studies using viral genetics. The propagation
of infectious clones of herpesviruses as bacterial artificial chro-
mosomes (BACs) has revolutionized the experimental manip-
ulation of viral genomes. Importantly, this technology has al-
lowed application of tools of prokaryotic molecular biology to
the study of viral genetics, thereby facilitating the genetic anal-
ysis of many herpesviruses (4–6, 16, 23, 24, 27). Previously,
mutagenic approaches based on homologous recombination in
eukaryotic cells were limited to genetic manipulation of only
the most rapidly replicating and promiscuous herpesviruses,
such as herpes simplex virus (HSV) and pseudorabies virus
(PRV) (19). In this study, we have adapted a recombination
strategy originally developed for mutagenesis of BACs con-
taining mouse chromosomes to mutagenize the human cyto-
megalovirus (HCMV) genome (8, 10, 25, 26). This methodol-
ogy takes advantage of a lambda phage recombination system
(RED locus) expressed from a temperature-sensitive promoter
that enables the use of linear single-stranded DNA to target
genes of interest carried on BACs maintained in Escherichia
coli (8, 26). We have used this recombination system together
with a blue/white lacZ-based selection approach to define the
importance of HCMV tegument protein pp28 (UL99) for
HCMV replication. The product of the HCMV UL99 open
reading frame (ORF) is a 190-amino-acid (aa) phosphorylated
tegument protein, which is modified by myristylation (17, 18,
21). Homologues of pp28 are found in all herpesviruses. Stud-
ies with the HSV homologue UL11 have indicated that this
protein is also myristylated, traffics in the cytoplasm, and is
essential for wild-type levels of virus replication in vitro (2, 3,
11–13). Furthermore, more recent studies of the PRV UL11
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FIG. 1. Construction of UL99 recombinant BACs. The genome of
HCMV AD169 is shown at the top with the UL99 ORF and its coordi-
nates listed below. This AD169 BAC was transferred to E. coli strain
DY380 for these experiments (25). The position of insertion of the Ampr
lacZ cassette in the UL99 deletion BAC (99KO) is shown. The UL99
deletion BAC, 99KO, was then repaired with 800-bp linear PCR products
encoding either wild-type sequences (99Rev) or mutant sequences
(99STOP and 99Myr) by previously described methods (10, 25, 26). The
sequences containing the point mutations in BACs 99STOP and 99Myr
along with the corresponding sequence of the wild-type repaired BAC,












have demonstrated that it also was required for virus replica-
tion and that viruses with deletions in UL11 were defective in
secondary cytoplasmic envelopment of tegumented capsids (9).
The HCMV pp28 is a true late protein that localizes in a
cytoplasmic assembly compartment, suggesting that the pro-
tein may be involved in late steps of viral morphogenesis such
as final tegumentation or envelopment (20). To date, it is
unknown whether pp28 is essential for the production of in-
fectious HCMV.
Our strategy for site-specific mutagenesis of the UL99 ORF
involved a two-step procedure. In the first step, the UL99 ORF
was deleted from a BAC-maintained HCMV genome by re-
placement with an Ampr lacZ cassette. Growth in the presence
of IPTG (isopropyl--D-thiogalactopyranoside)–X-Gal (5-bro-
mo-4-chloro-3-indolyl--D-galactopyranoside) enables identifi-
cation of HCMV recombinants by visual inspection for blue
bacterial colonies. The mutagenesis was performed with RED
locus-mediated recombination to delete sequences between
positions 145310 and 145795 of the AD169 genome in the HB5
BAC (kindly provided by Martin Messerle and Ulrich Kozsi-
nowski, University of Munich) (4). A primer set amplifying
sequences from positions 145210 (forward primer) and 146025
(reverse primer) was used to produce a recombination cassette
of approximately 2.0 kbp that carried the Ampr lacZ cassette
together with approximately 100 to 200 bp of AD169 sequence
flanking the site of deletion within the HCMV genome (Fig. 1).
The cassette was recombined into the AD169 BAC by RED
locus-mediated recombination using the protocol described by
Lee et al., resulting in production of greater than 200 Ampr
blue colonies (10). Insertion of the cassette resulted in the
deletion of the entire UL99 ORF except for 100 bp of the 3
end (recombinant designated 99KO BAC; Fig. 1). To ensure
correct targeting of the recombination cassette into the desired
genomic location, recombinant BAC DNA was digested with
HindIII, electrophoresed, and transferred to nitrocellulose
membranes, followed by hybridization using a 32P-labeled
probe directed against the Ampr lacZ cassette. Analysis of
three independent clones revealed a single 8.0-kbp fragment
that hybridized to the probe. This fragment corresponds to the
6-kbp UL99 ORF containing a HindIII R fragment that was
increased in size by 2.0 kbp following insertion of the Ampr
lacZ cassette into this region (Fig. 2A). Nucleotide sequence
analysis of PCR products amplified from these recombinant
BACs confirmed correct insertion of the Ampr lacZ cassette
and replacement of the UL99 ORF (data not shown).
In the second step, RED recombination was used to replace
the UL99 deletion in 99KO BAC with either the wild-type
UL99 ORF sequence or the UL99 sequence containing desired
FIG. 2. Analysis of 99KO, 99STOP, and 99Myr BAC by Southern hybridization. (A) DNA prepared from three independent blue, ampicillin-
resistant colonies of BAC-containing E. coli that had been recombined with the linear Ampr lacZ cassette were digested with HindIII, subjected
to electrophoresis in agarose gel, and transferred to nitrocellulose membranes. Hybridization was carried out with a 32P-labeled probe generated
by nick translation of DNA containing the Ampr lacZ cassette. Arrow, migration of the approximately 8-kbp HindIII fragment containing the Ampr
lacZ cassette. Note that a single fragment hybridized with the probe, indicating a single site of insertion. (B) DNA prepared from E. coli containing
the wild-type AD169 BAC (AD169), 99KO BAC, mutant 99STOP BAC, and mutant 99Myr BACs was digested with HindIII and analyzed as
described for panel A by Southern hybridization with a 32P-labeled probe generated by nick translation of DNA containing the intact UL99 ORF.
Arrow, migration of the HindIII R fragment at approximately 6 kbp. The weak signal in the lane containing the 99KO DNA is secondary to the
approximate 100 bp of the 3 end of the UL99 ORF that remains following this insertion and deletion.
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mutations by using a linear DNA fragment. Recombination
removes the Ampr lacZ cassette from the 99KO BAC, and
repaired or mutagenized recombinants can be simply and rap-
idly identified by visual inspection for white colonies. The same
primer set described above was used to prepare linear DNA
fragments containing the desired mutations by PCR from a
UL99 template as previously described (10, 25). The first mu-
tation consisted of a single nucleotide substitution at position
145333 that altered a glutamic acid codon (GAA) to a stop
codon (TAA; recombinant designated 99STOP BAC; Fig. 1).
The second mutation was positioned at 145328 and changed a
glycine codon (GGT) to an alanine codon (GCT; recombinant
designated 99Myr BAC; Fig. 1). This second mutation was
introduced to delete the myristylation site that we have previ-
ously shown to be critical for intracellular localization of the
UL99-encoded pp28 protein (21). A revertant containing the
wild-type UL99 ORF sequence (designated 99Rev BAC) was
also prepared to ensure that any observed phenotype was a
result of the UL99 ORF mutation. Gel-purified PCR products
were recombined into the 99KO BAC, and E. coli cells carrying
BACs with the desired UL99 ORF mutations were readily
recovered after overnight incubation at 30°C on X-Gal plates
by selection of white colonies. In multiple experiments the
frequency of white colonies varied from 0.8 to 0.1%.
Analysis of the mutagenized BACs demonstrated that the
UL99 deletion BAC (99KO BAC) had been repaired. DNA
prepared from the mutagenized BACs was digested with Hin-
dIII and analyzed by agarose gel electrophoresis, followed by
Southern transfer to nitrocellulose membranes and hybridiza-
tion. The membrane was probed with a 32P-labeled probe
generated by nick translation of the entire UL99 ORF. Both
the 99STOP and 99Myr mutagenized BACs had the same
restriction fragment pattern as that observed for the parental
wild type, AD169, including the 6-kbp HindIII fragment, which
was absent from the 99KO BAC (Fig. 2B). The UL99 32P-
labeled probe hybridized with the 6-kbp fragment in both mu-
tant BACs and the wild-type AD169 BAC (Fig. 2B). A weak
UL99-specific signal was also observed for the 8.0-kbp frag-
ment in the 99KO BAC, presumably derived from hybridiza-
tion to the 100 bp of the UL99 ORF that remains within this
BAC (Fig. 2B). The same primer set was also used to amplify
DNA from the BACs and readily amplified the expected
800-bp product from the parental AD169 BAC as well as those
from the two mutagenized BACs, 99STOP and 99Myr BAC
(Fig. 3A). A 2.0-kb fragment was amplified from the 99KO
BAC as predicted due to the presence of the Ampr lacZ cas-
sette (Fig. 3A). Sequence analysis of PCR products from
99STOP and 99Myr BAC confirmed the presence of the
expected mutation and complete fidelity of the UL99 sequence
following comparison with the published sequence of AD169
(with the exception of the introduced point mutations) (Fig. 1).
Similarly, PCR amplification of the 99Rev BAC produced the
expected 800-bp fragment (Fig. 3B), and sequence analysis
revealed that this PCR product was identical to the parental
AD169 nucleotide sequence (7).
To determine whether the UL99 gene was essential for virus
infectivity in normal human dermal fibroblasts (NHDF), DNA
was purified from the BAC-containing E. coli cells and elec-
troporated into NHDF. Infectivity was monitored by observing
the production of visible plaques and by assaying cells from
NHDF monolayers for expression of HCMV-encoded proteins
with HCMV monoclonal antibodies (MAbs) reactive with
FIG. 3. PCR analysis of 99KO, 99STOP, 99Myr, and the wild-type repaired (99Rev) BACs. (A) DNA from 99KO, 99STOP, or 99Myr BACs
was amplified by primer pairs used to generate the recombination cassette, and the resulting products were analyzed by agarose gel electrophoresis.
The expected product from the wild-type parent BAC (AD169) was approximately 800 bp. The amplimers from the 99STOP and 99Myr mutant
BACs migrated similarly, whereas the amplimer of the 99KO BAC was approximately 1.2 kbp larger. (B) DNA from the wild-type parent BAC
(AD169), the 99KO BAC, and the wild-type repaired BAC, 99Rev, was amplified as described for panel A, and the amplimers were analyzed by
agarose gel electrophoresis. The amplimers of the wild-type parent BAC and the wild-type repaired BAC migrated at approximately 800 bp.
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IE-1, pp28, and gB. Infectious virus was consistently recovered
from both the wild-type parental AD169 BAC DNA and from
the 99Rev wild-type revertant BAC DNA (Table 1). Similarly,
MAb reactivity for IE-1, pp28, and gB was observed in cells
that had been electroporated with the parental AD169 BAC
and 99Rev BAC (Table 1). In contrast, in multiple experiments
(at least four independent experiments) infectious virus was
never recovered from NHDF electroporated with DNA from
BACs containing either the 99STOP or the 99Myr mutation,
suggesting that the pp28 gene is essential for the production of
infectious HCMV (Table 1). Importantly, the inability of
99Myr to produce infectious virus suggests that that correct
localization of pp28 due to the presence of the myristic acid
modification may be critical for virus infectivity.
The recombination strategy we have described in this report
provides a simple and rapid method to introduce site-specific
mutations into the HCMV genome. Once the viral sequence of
interest has been replaced by the Ampr lacZ cassette, repair of
this BAC with either wild-type sequences or sequences con-
taining specific mutation can be accomplished within 2 days.
Importantly, as opposed to other approaches, our approach
enables insertion of only the specific mutations within the
herpesvirus genome without leaving residual foreign sequences
(e.g., frt sites). In our experience, this recombination procedure
has consistently allowed recombination into a predicted site
and unexpected recombination or deletion in the parental
BAC has been observed only infrequently. We have used this
approach to introduce stop codons at various positions in the
UL99 sequence as well as to introduce mutations into the
UL55, UL100, UL73, and UL32 ORFs (data not shown). In
each case, the targeting of the Ampr lacZ cassette and the
subsequent repair of the deletion mutation has been confirmed
by both Southern hybridization and sequence analysis. Thus,
we believe that this adaptation of the powerful technology
originally developed by Court et.al. offers a rapid and repro-
ducible method to introduce specific mutations into the
HCMV genome (10, 25, 26).
Our finding that the tegument protein, pp28, was an essen-
tial protein for in vitro replication of HCMV was not unex-
pected. Previous studies using HSV have demonstrated that
the UL99 homologue, UL11, was not essential for virus repli-
cation, but UL11 deletion mutants produced several orders of
magnitude less virus than wild-type HSV or PRV (3, 9). The
99STOP mutation resulted in a translational stop after the
second codon of the pp28 gene. This mutation did not alter the
coding sequence of the overlapping UL98 ORF, a gene encod-
ing the alkaline nuclease that is likely required for HCMV
replication (1). The mutation present in 99Myr BAC changed
aa 567 of ppUL98 from a valine to a leucine. This is a conser-
vative change, and, more importantly, this residue lies outside
of any conserved domains or motifs that have been assigned to
herpesvirus alkaline nucleases based on amino acid alignment
(15, 22). In addition, alignment of the reported amino acid
sequence of alkaline nucleases from other alpha-, beta-, and
gammaherpesviruses revealed that the region surrounding
HCMV UL98 aa 567 was highly variable and in only one
instance was the valine conserved at this position. Conse-
quently, we believe that this mutation introduced into the
ppUL98 amino acid sequence does not account for the null
phenotype of the 99Myr mutant. The more probable expla-
nation is that the 99Myr mutant encodes a pp28 that lacks a
myristic acid modification and is mislocalized compared to the
myristylated protein of the wild-type virus. This suggests that
authentic intracellular localization of pp28 is required for
HCMV morphogenesis.
We have not discerned the step in virus replication that is
blocked by mutations in pp28. However, the block is presum-
ably at a late step in virion morphogenesis, since pp28 is a true
late protein that is produced following expression of virion
glycoproteins and other structural proteins such as capsid pro-
teins (20). Furthermore, the assembly compartment in virus-
infected cells has been shown to contain HCMV structural
proteins prior to the detection of pp28 or localization of this
protein within the assembly compartment (20). Consistent with
this interpretation were findings that early-late and late
HCMV proteins (pp65/UL38, pp150/UL32, MCP/UL86,
pp52/UL44, and gB/UL55) could be detected in single cells
from cultures electroporated 7 to 10 days earlier with DNA
from either the 99Myr or 99STOP mutant BAC (data not
shown). These results suggested that the block in virus repli-
cation was late in the replicative cycle of the virus, possibly in
the assembly of the infectious particle. Because pp28 cannot be
detected in the nucleus at any time during its expression in
infected cells, our findings also provide strong support that
envelopment of infectious virions takes place in the cytoplasm,
likely in proximity to the assembly compartment, and that pp28
plays an integral role in the latter stages of this process. Our
recent observations have demonstrated that pp28 interacts
with HCMV glycoproteins including gB (unpublished data)
and raise the possibility that pp28 could serve either a targeting
or adaptor function in the final steps of virion assembly. Im-
portantly, with the availability of a rapid HCMV mutagenesis
system, the functions of specific domains of the pp28 molecule
that have been defined in transient expression assays should
now be possible within the context of replicating virus.
We thank Don Court (National Cancer Institute, Frederick, Md.),
Martin Messerle and Ulrich Kozsinowski (University of Munich), and
TABLE 1. Recovery of infectious virus from HCMV BAC DNAa








a Approximately 3 to 6 g of BAC DNA plus 1 g of a plasmid DNA encoding
pp71 were electroporated into human fibroblasts under conditions previously
described (14). The efficiency of electroporation was monitored by including 0.5
g of an expression plasmid encoding enhanced green flurescent protein in each
electroporation. Typical HCMV plaques were observed between 12 and 16 days
following electroporation, and cells were cultured for approximately 3 weeks
prior to assaying for infectivity.
b Infectious virus was determined by the appearance of plaques in monolayers
of human fibroblasts and the capacity of a freeze-thaw lysate of cells to transfer
infectious virus to an uninfected monolayer of NHDF cells. Values are the
numbers of times that virus was recovered/the numbers of experiments.
c Expression of virus-encoded proteins in electroporated cells was determined
by reactivity of fixed cells harvested 3 weeks following electroporation with MAbs
reactive with IE-1, gB, and pp28 as determined in a immunofluorescence assay
(20). Values are numbers of times reactivity with all MAbs was observed/the total
number of experiments.
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